Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Replicel Life Sciences Inc V.RP

Alternate Symbol(s):  REPCF

RepliCel Life Sciences Inc. is a Canada-based regenerative medicine company. The Company is focused on developing cell therapies for aesthetic and orthopedic conditions, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. The Company’s cell therapy product pipeline is comprised of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair restoration. RCH-01 is an autologous cell therapy utilizing dermal sheath cup (DSC) cells isolated from the hair follicle to treat androgenetic alopecia. RCS-01 is an autologous cell therapy utilizing non-bulbar dermal sheath (NBDS) cells, a type of fibroblast cell isolated from the hair follicle to repair and regenerate tissue. RCT-01 provides a source of collagen expressing cells to the site of injury, addressing the underlying cause of tendinosis. It has also developed an injection device, DermaPrecise, which improves the administration of its cell therapy products and certain other injectables.


TSXV:RP - Post by User

Comment by bluemoons20on Apr 02, 2024 11:13am
91 Views
Post# 35965164

RE:RE:RE:Do we understand what we are voting on ?

RE:RE:RE:Do we understand what we are voting on ?unfortunately, this situation  has got  me to thinking (which can be dangerous!)  Believe  we  get  the  85  based on sale of the assets.

Andrew  is likely  focused on  getting his money  back.  Once that is done  he could  sell the other assets  for  say $1  with a  royalty  back to  him  having  met the  Sale requirement  and thus  leave  a lot of the  futures  out of Replical  hands.  and ending any royalty  potential.

Secondly,  given that the company  will be  DELISTED  -  who is going to track  shareholders and  who and where to pay  any potential  royalty.  Surely  that type of service would cost  something??

Thirdly -  now that i  have a delisted company,  if I  write it off  for tax  purposes  (I  am supposed to  divest myself of the stock)  thus in that case i  would not be eligible for  any potential royalities  - Who will track this  so  only  current  shareholder owners  will get  whatever might be offered??

Anyone here  have ab insight into  some of these issues.

GLTA

<< Previous
Bullboard Posts
Next >>